BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Karam S, Margaria JP, Bourcier A, et al. (2020) Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure. Circulation |
| Mougenot N, Mika D, Czibik G, et al. (2020) Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction. Cardiovascular Research. 115: 1778-1790 |
| Mika D, Bobin P, Lindner M, et al. (2019) Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model. Journal of Molecular and Cellular Cardiology. 133: 57-66 |
| Bedioune I, Bobin P, Karam S, et al. (2016) [Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives]. Biologie Aujourd'Hui. 210: 127-138 |
| Bobin P, Belacel-Ouari M, Bedioune I, et al. (2016) Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective. Archives of Cardiovascular Diseases |
| Haj Slimane Z, Bedioune I, Lechêne P, et al. (2014) Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes. Cardiovascular Research. 102: 97-106 |
| Zhai K, Chang Y, Wei B, et al. (2014) Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms. Cellular Signalling. 26: 1001-10 |
| Mika D, Bobin P, Pomérance M, et al. (2013) Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes. Cardiovascular Research. 100: 336-46 |
| Mehel H, Emons J, Vettel C, et al. (2013) Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. Journal of the American College of Cardiology. 62: 1596-606 |
| Ghigo A, Perino A, Mehel H, et al. (2012) Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. Circulation. 126: 2073-83 |